CD11B AGONISTS FOR TREATMENT OF AUTOIMMUNE DISEASE

ANTI-PD1 THERAPY BASED ON RESPONSE TO IFN-I STIMULATION

IMMUNOSTIMULATORY BACTERIA FOR CONVERTING MACROPHAGES INTO A PHENOTYPE AMENABLE TO TREATMENT, AND COMPANION DIAGNOSTIC FOR IDENTIFYING SUBJECTS FOR TREATMENT

METHODS FOR DETERMINING TUMOR IMMUNE STATUS

ADJUVANT FOR VACCINE DEVELOPMENT

IFNbeta as a Pharmacodynamic Marker in VSV-IFNbeta-NIS Oncolytic Therapy

Combination of a PD-1 antagonist, an ATR inhibitor and a platinating agent for the treatment of cancer

IFN-beta Reporter System for Primary Cells

COMPOSITIONS AND METHODS RELATED TO INNATE RESPONSE TO DNA AND REGULATION OF INTERFERON-BETA

Early Diagnosis of Autoimmune and Inflammatory Disorders

Biomarkers for assessing subjects with multiple sclerosis

Early Diagnosis of Autoimmune and Inflammatory Disorders

Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (RRMS) patient, and method for determining applicability of novel therapy

Markers for determination of patient responsiveness

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE

USE OF POST-TRANSCRIPTIONAL GENE SILENCING FOR IDENTIFYING NUCLEIC ACID SEQUENCES THAT MODULATE THE FUNCTION OF A CELL

Methods For Determining Anti-TNF Therapeutic Response

Retrieval of biological materials from the human uterus, ovary and cervix by suction

Methods for determining anti-TNF therapeutic response

Methods for stimulating tlr irf3 pathways for inducing anti-microbial, anti-inflammatory and anticancer responses

TRIF-related adaptor molecule (TRAM) and uses thereof

Polymer conjugates of interferon-beta with enhanced biological potency